AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

Study shows key role for human T cells in the control of Respiratory Syncytial Virus (RSV) infection Date: May 24, 2023 Source: University of North Carolina Health Care Summary: A new study has ...

The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

WHAT WE FOUND Human Metapneumovirus (HMPV) is not new. The respiratory virus was first identified in 2001, according to the Centers for Disease Control and Prevention.

Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in ...

(Reuters) -French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio ...

It is a seasonal disease that usually occur s in the winter and early spring, similar to Respiratory Syncytial Virus (RSV) and the flu. In the US, HMPV circulates in distinct annual seasons.

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV ...

It's called human metapneumovirus (HMPV). "The symptoms are identical almost to influenza and respiratory syncytial virus," said Dr. Jorge Rodriguez, a board-certified internal medicine specialist.

But hMPV, which causes respiratory tract infections similar to colds and flu, is not new in China or elsewhere in the world and, as of Jan. 9, Chinese officials have not declared any emergency ...